SCHEMBL4664548

SCHEMBL4664548

CC(=O)C(C)(CCc1ccccc1)C(N)=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
LMNA P02545 2/20 0.45
MAPT P10636 3/20 0.43
KMT2A Q03164 3/20 0.43
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
POLB P06746 1/20 0.41
KEAP1 Q14145 1/20 0.41
GRM2 Q14416 1/20 0.41
GRM3 Q14832 1/20 0.41
MEN1 O00255 1/20 0.41
HTT P42858 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
SSTR4 P31391 1/20 0.40
MMP8 P22894 2/20 0.40
HDAC3 O15379 2/20 0.40
HDAC4 P56524 2/20 0.40
HDAC1 Q13547 2/20 0.40
HDAC7 Q8WUI4 2/20 0.40
HDAC2 Q92769 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27825984 0.86 ALDH1A1 (0.50) ALDH1A1MAPTKMT2ANPC1RAB9A
SCHEMBL6803588 0.82 HDAC3 (0.50) ALDH1A1LMNAMAPTKMT2ANPC1
SCHEMBL5320849 0.79 MAPT (0.46) ALDH1A1LMNAMAPTKMT2ANPC1
SCHEMBL27957913 0.79 AR (0.47) ALDH1A1LMNAMAPTKMT2ANPC1
SCHEMBL9190217 0.79 GRM2 (0.46) ALDH1A1LMNAMAPTKMT2ANPC1
SCHEMBL8287226 0.78 ALDH1A1 (0.53) ALDH1A1MAPTKMT2ANPC1RAB9A
SCHEMBL22781383 0.77 ALDH1A1 (0.52) ALDH1A1MAPTKMT2ANPC1RAB9A
SCHEMBL28487224 0.76 SMN1; SMN2 (0.46) ALDH1A1LMNAMAPTKMT2ANPC1
SCHEMBL4560574 0.76 MAPT (0.52) ALDH1A1LMNAMAPTKMT2ANPC1
SCHEMBL6192939 0.76 POLB (0.49) ALDH1A1LMNAMAPTKMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1613606-A4 METHODS FOR PREPARING 2,3,5,6-SUBSTITUTED 3H-PYRIMIDIN-4-ONES NPS PHARMA INC (US) 2008-12-03 EP disclosed
EP-1615897-A4 PYRIMIDINONE COMPOUNDS AS CALCILYTICS NPS PHARMA INC (US) 2008-07-23 EP disclosed
EP-1615897-A2 PYRIMIDINONE COMPOUNDS AS CALCILYTICS NPS PHARMACEUTICALS, INC. (US) 2006-01-18 EP disclosed
EP-1613606-A2 METHODS FOR PREPARING 2,3,5,6-SUBSTITUTED 3H-PYRIMIDIN-4-ONES NPS PHARMACEUTICALS, INC. (US) 2006-01-11 EP disclosed
WO-2004092121-A2 METHODS FOR PREPARING 2,3,5,6-SUBSTITUTED 3H-PYRIMIDIN-4-ONES NPS PHARMACEUTICALS, INC. (US) 2004-10-28 WO disclosed
WO-2004092120-A2 PYRIMIDINONE COMPOUNDS AS CALCILYTICS NPS PHARMACEUTICALS, INC. (US) 2004-10-28 WO disclosed